Viwit Pharmaceuticals Limited (Viwit), founded in 2006, is a fast-growing research-based pharmaceutical company. Based on our strong technology and well-organized cGMP production platform, Viwit is also a contract development and manufacturing organization (CDMO) serving the pharmaceutical industry worldwide. Viwit specializes in multi-step synthetic processes in batch sizes from grams to tons to support clinical trials from Phase I to Phase III to post-launch production. Viwit aims to shorten the lead time and lower the cost of new drug development. Till now Viwit has already developed and manufactured more than 35 generic APIs and formulations, mainly in diabetes, anti-fungal, ophthalmic, oncology, smoking cessation, MRI contrast agent and cardiovascular therapeutic areas.